AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
A paper published in the August issue of Annals of Neurology reported a case of cerebral edema in an 80-year-old woman following abrupt withdrawal from pregabalin (Lyrica), an antiepileptic drug made by Pfizer with expected release this fall. Suffering from severe pain associated with shingles, the woman was taking part in a clinical trial. Within a week after terminating the drug, she experienced delirium and …